Publicaciones (33) Publicaciones de JOSE ANTONIO MORALES MOLINA

2022

  1. Pain management & opioid dose reduction with topical sevoflurane instillations in intractable venous ulcers: a case report

    Brazilian Journal of Pharmaceutical Sciences, Vol. 58

  2. Preparation and ex vivo investigation of an injectable microparticulate formulation for gastrointestinal mucosa polyp resection

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 178, pp. 25-34

2021

  1. New formulations loading caspofungin for topical therapy of vulvovaginal candidiasis

    Gels, Vol. 7, Núm. 4

2020

  1. Efficacy and safety of a novel submucosal injection solution for resection of gastrointestinal lesions

    Journal of Clinical Medicine, Vol. 9, Núm. 4

  2. Novel polymeric formulation for removal of gastrointestinal polyps by digestive endoscopy

    Pharmaceutics, Vol. 12, Núm. 4

  3. Pain reduction of topical sevoflurane vs intravenous opioids in pressure ulcers

    International Wound Journal, Vol. 17, Núm. 1, pp. 83-90

2019

  1. Identification and prioritisation of risks in a hospital pharmacy using healthcare failure mode and effect analysis

    European Journal of Hospital Pharmacy , Vol. 26, Núm. 2, pp. 66-72

  2. Palliative analgesia with topical sevoflurane in cancer-related skin ulcers: A case report

    European Journal of Hospital Pharmacy , Vol. 26, Núm. 4, pp. 229-232

  3. Polyols: Is their use safe in enteral nutrition?

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 6, pp. 393-395

2018

  1. Delayed pancytopenia due to treatment with levofloxacin: A case report

    Farmacia Hospitalaria, Vol. 42, Núm. 1, pp. 22-24

2017

  1. Efficacy and safety of topical sevoflurane in the treatment of chronic skin ulcers

    American Journal of Health-System Pharmacy, Vol. 74, Núm. 9, pp. e176-e182

  2. Sevoflurano tópico: una nueva opción terapéutica paliativa en las úlceras cutáneas

    Medicina Paliativa, Vol. 24, Núm. 2, pp. 104-108

2016

  1. Clinical Management of Cirrhotic Patient With HCV Genotype 5 Treated With Simeprevir, Sofosbuvir, and Ribavirin

    Annals of Pharmacotherapy

2015

  1. Biosimilars, the journey has begun

    Farmacia Hospitalaria, Vol. 39, Núm. 2, pp. 114-117

2014

  1. Interaction between fibrates and acenocoumarol

    Atencion Farmaceutica, Vol. 16, Núm. 2, pp. 154-156

2013

  1. Evaluation of patient satisfaction in outpatient pharmacy unit

    Atencion Farmaceutica, Vol. 15, Núm. 6, pp. 397-405

  2. Interaction between ciclopirox and acenocoumarol

    European Journal of Clinical Pharmacology

2012

  1. Interaction between amorolfine and acenocoumarol

    European Journal of Clinical Pharmacology

2011

  1. Bosentan and oral anticoagulants in HIV patients: what we can learn of cases reported so far

    Hematology Reports, Vol. 3, Núm. 2

2010

  1. Características clínicas diferenciales entre las bacteriemias por Enterococcus faecalis y Enterococcus faecium

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 6, pp. 342-348